: "“Non-inferior” sounds like an awfully low bar—even damning by faint praise—until we look at the many, albeit modest downsides of each shot: finding when they’re available, queuing, needle anxiety, soreness/reax. And clinics’ logistics of one SKU vs two. This looks like a solid win🏆for public health"

@waltfrench.bsky.social

“Non-inferior” sounds like an awfully low bar—even damning by faint praise—until we look at the many, albeit modest downsides of each shot: finding when they’re available, queuing, needle anxiety, soreness/reax. And clinics’ logistics of one SKU vs two. This looks like a solid win🏆for public health

Jun 10, 2024 at 16:19 UTC

0 replies 0 reposts 2 likes